Terumo Corp. (OTCMKTS:TRUMY) Sees Significant Decrease in Short Interest

Terumo Corp. (OTCMKTS:TRUMY) was the target of a large drop in short interest in September. As of September 15th, there was short interest totaling 31,506 shares, a drop of 71.2% from the August 31st total of 109,382 shares. Based on an average daily volume of 135,496 shares, the short-interest ratio is currently 0.2 days. Approximately 0.0% of the shares of the stock are short sold.

Terumo Stock Performance

OTCMKTS:TRUMY opened at $14.59 on Friday. Terumo has a twelve month low of $12.08 and a twelve month high of $17.81. The firm’s fifty day simple moving average is $15.05 and its 200 day simple moving average is $14.09. The company has a current ratio of 2.19, a quick ratio of 1.37 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $21.52 billion, a price-to-earnings ratio of 20.55 and a beta of 0.68.

Terumo (OTCMKTS:TRUMY) last posted its earnings results on Friday, August 7th. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.13. Terumo had a return on equity of 10.44% and a net margin of 13.83%.The business had revenue of $1.97 billion during the quarter, compared to analyst estimates of $1.84 billion. As a group, equities research analysts expect that Terumo will post 0.7 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Nomura raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Buy”.

About Terumo

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other health care settings. Founded in 1921, the company has grown from producing clinical thermometers into a global provider of medical devices and related solutions.

Terumo’s businesses include cardiovascular and vascular intervention products, such as catheters, guidewires and other devices used in the treatment of heart and vascular conditions.